KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Prepaid Assets (2016 - 2025)

Regeneron Pharmaceuticals has reported Prepaid Assets over the past 17 years, most recently at $474.8 million for Q4 2025.

  • Quarterly results put Prepaid Assets at $474.8 million for Q4 2025, up 35.97% from a year ago — trailing twelve months through Dec 2025 was $474.8 million (up 35.97% YoY), and the annual figure for FY2025 was $474.8 million, up 35.97%.
  • Prepaid Assets for Q4 2025 was $474.8 million at Regeneron Pharmaceuticals, down from $595.6 million in the prior quarter.
  • Over the last five years, Prepaid Assets for REGN hit a ceiling of $681.9 million in Q2 2024 and a floor of $213.6 million in Q1 2021.
  • Median Prepaid Assets over the past 5 years was $434.6 million (2021), compared with a mean of $452.2 million.
  • Biggest five-year swings in Prepaid Assets: soared 109.02% in 2021 and later plummeted 37.23% in 2023.
  • Regeneron Pharmaceuticals' Prepaid Assets stood at $332.4 million in 2021, then grew by 23.71% to $411.2 million in 2022, then fell by 5.98% to $386.6 million in 2023, then dropped by 9.67% to $349.2 million in 2024, then soared by 35.97% to $474.8 million in 2025.
  • The last three reported values for Prepaid Assets were $474.8 million (Q4 2025), $595.6 million (Q3 2025), and $574.3 million (Q2 2025) per Business Quant data.